TrialHepatology international2021
Low-dose rifaximin prevents complications and improves survival in patients with decompensated liver cirrhosis.
Xin Zeng et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
29 papers cite it
this paperpooled itcites it